Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years
about
Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.Quality of screening with conventional Pap smear in Austria - a longitudinal evaluation.Expenditure and resource utilisation for cervical screening in Australia.Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use.Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New ZealandOptimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in AustraliaCost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites StudyModeling preventative strategies against human papillomavirus-related disease in developed countriesCost effectiveness of human papillomavirus-16/18 genotyping in cervical cancer screeningExploiting biospectroscopy as a novel screening tool for cervical cancer: towards a framework to validate its accuracy in a routine clinical setting.Cervical cancer in women under 25 years of age in Queensland, Australia: To what extent is the diagnosis made by screening cytology?Excess cervical cancer screening smears: Any benefit? A retrospective cohort in Alsace, France.Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries.Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia.The recommended interval for cervical cancer screening: Victorian women's attitudes to an extended interval.Simple but not simpler: a systematic review of Markov models for economic evaluation of cervical cancer screening.
P2860
Q30251868-7289EB77-20BD-4D25-9FA0-ACCF43D2CA9FQ33588387-8EFED0B3-D424-4EDB-9FD8-FC8E5526A5C1Q34502683-D66332EE-3E42-4AEE-A1B7-568E3975DB29Q35998533-79C53028-D04D-44D6-A23D-6EF053C2A965Q36019886-07DBD95C-B247-4C45-9C54-9A5ED8BFE766Q36251151-2171F9DE-ED39-4319-A5AB-9387C9A761DFQ36365585-5EC6DA22-5A20-47AD-B6FC-B7781C766178Q37198208-897F7461-DE94-4259-B507-05A29BBA5032Q37273434-182A3ED4-E61A-4BCC-8FA2-E17C54F0816EQ38158188-6B69004F-06B3-4FA3-9995-D572167B9FA3Q38744395-27EB6D2B-3131-486D-9A62-ABBF19E0A66FQ39748808-9344251F-49A9-4C6E-B6E3-D0EF873A03BAQ40569845-C283BA47-15C1-44E0-9755-15C1532609DAQ50000948-2D311257-0239-4F2A-810F-DE63D9B42195Q51004606-5BBF061D-69BF-4EF6-B415-F9F7DF2B1CB6Q55397815-24AC425F-05E4-4174-B28A-C68D0E78308D
P2860
Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cervical cancer screening in A ...... terval from two to three years
@ast
Cervical cancer screening in A ...... terval from two to three years
@en
type
label
Cervical cancer screening in A ...... terval from two to three years
@ast
Cervical cancer screening in A ...... terval from two to three years
@en
prefLabel
Cervical cancer screening in A ...... terval from two to three years
@ast
Cervical cancer screening in A ...... terval from two to three years
@en
P2093
P2860
P50
P356
P1433
P1476
Cervical cancer screening in A ...... terval from two to three years
@en
P2093
Karen Canfell
Kirsten Howard
Mark Clements
Prudence Creighton
P2860
P2888
P356
10.1186/1471-2458-10-734
P407
P577
2010-11-26T00:00:00Z
P5875
P6179
1027360687